BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 27805501)

  • 1. Tolerance in Solid-Organ Transplant.
    Fine RN
    Exp Clin Transplant; 2016 Nov; 14(Suppl 3):1-5. PubMed ID: 27805501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory T cells as a therapeutic tool to induce solid-organ transplant tolerance: current clinical experiences.
    Nikoueinejad H; Sharif MR; Amirzargar A; Mirshafiey A; Einollahi B
    Exp Clin Transplant; 2013 Oct; 11(5):379-87. PubMed ID: 23902519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinically feasible approach to induce delayed tolerance in recipients of prior kidney or vascularized composite allotransplants.
    Chen B; Xu H; Corbin DR; Ildstad ST
    Transplantation; 2012 Oct; 94(7):671-8. PubMed ID: 22948444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Operational tolerance: past lessons and future prospects.
    Levitsky J
    Liver Transpl; 2011 Mar; 17(3):222-32. PubMed ID: 21384504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers and possible mechanisms of operational tolerance in kidney transplant patients.
    Dugast E; Chesneau M; Soulillou JP; Brouard S
    Immunol Rev; 2014 Mar; 258(1):208-17. PubMed ID: 24517435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harnessing regulatory T cells for transplant tolerance in the clinic through mTOR inhibition: myth or reality?
    Zuber J; Hermine O; Chatenoud L; Legendre C
    Curr Opin Organ Transplant; 2011 Dec; 16(6):606-13. PubMed ID: 21971509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoregulation and tolerance.
    Knechtle SJ
    Transplant Proc; 2010 Nov; 42(9 Suppl):S13-5. PubMed ID: 21095443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some observations on prope tolerance.
    Calne R; Watson CJ
    Curr Opin Organ Transplant; 2011 Aug; 16(4):353-8. PubMed ID: 21666472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of immune tolerance in liver transplantation].
    Pons JA; Revilla-Nuin B; Ramírez P; Baroja-Mazo A; Parrilla P
    Gastroenterol Hepatol; 2011 Mar; 34(3):155-69. PubMed ID: 21376423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment strategies in pediatric solid organ transplant recipients with calcineurin inhibitor-induced nephrotoxicity.
    Tönshoff B; Höcker B
    Pediatr Transplant; 2006 Sep; 10(6):721-9. PubMed ID: 16911497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What do we know about the clinical impact of complete withdrawal of immunosuppression in liver transplantation?
    Pons JA; Revilla Nuin B; Ramírez P; Baroja Mazo A; Martínez Alarcón L; Robles R; Sánchez Bueno F; Rios A; Cascales Campos P; Parrilla P
    Transplant Proc; 2012; 44(6):1530-2. PubMed ID: 22841204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell therapy in transplantation: A comprehensive review of the current applications of cell therapy in transplant patients with the focus on Tregs, CAR Tregs, and Mesenchymal stem cells.
    Mansourabadi AH; Mohamed Khosroshahi L; Noorbakhsh F; Amirzargar A
    Int Immunopharmacol; 2021 Aug; 97():107669. PubMed ID: 33965760
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Manzia TM; Angelico R; Gazia C; Lenci I; Milana M; Ademoyero OT; Pedini D; Toti L; Spada M; Tisone G; Baiocchi L
    World J Gastroenterol; 2019 Sep; 25(35):5356-5375. PubMed ID: 31558879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune Tolerance Induction Using Cell-Based Strategies in Liver Transplantation: Clinical Perspectives.
    Wang P; Jiang Z; Wang C; Liu X; Li H; Xu D; Zhong L
    Front Immunol; 2020; 11():1723. PubMed ID: 33013824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reflections on the unique tolerogenicity of bone marrow, the enigma of chimerism and clinical tolerance.
    Monaco AP
    Clin Transpl; 2013; ():157-66. PubMed ID: 25095504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of T cells in graft rejection and transplantation tolerance.
    Issa F; Schiopu A; Wood KJ
    Expert Rev Clin Immunol; 2010 Jan; 6(1):155-69. PubMed ID: 20383898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Living-donor liver transplantation at the University of Tokyo, 1996-2011: the impact of HLA matching and a positive crossmatch on long-term survival and tolerance.
    Waki K; Sugawara Y; Mizuta K; Fujita H; Kadowaki T; Kokudo N
    Clin Transpl; 2011; ():223-35. PubMed ID: 22755416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Importance of Bringing Transplantation Tolerance to the Clinic.
    Cosimi AB; Ascher NL; Emond JC; Kaufman DB; Madsen JC; Miller J; Monaco AP; Montgomery RA; Newell KA; Sánchez-Fueyo A; Sarwal MM; Scandling JD; Strober S; Todo S; Weir MR; Sachs DH
    Transplantation; 2021 May; 105(5):935-940. PubMed ID: 33901128
    [No Abstract]   [Full Text] [Related]  

  • 19. Approaching the promise of operational tolerance in clinical transplantation.
    Bishop GA; Ierino FL; Sharland AF; Hall BM; Alexander SI; Sandrin MS; Coates PT; McCaughan GW
    Transplantation; 2011 May; 91(10):1065-74. PubMed ID: 21544029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal stromal cells in renal transplantation: opportunities and challenges.
    Casiraghi F; Perico N; Cortinovis M; Remuzzi G
    Nat Rev Nephrol; 2016 Apr; 12(4):241-53. PubMed ID: 26853275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.